{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:33:07Z","timestamp":1780677187108,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009827","name":"Alexandria University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009827","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>With the availability of several similar medical devices performing the same function, choosing one for reimbursement is not easy, especially if purchased for a large number of patients. The objective of this project was to create a multicriteria decision analysis (MCDA) tool, that captures and compares all implantable medical devices\u2019 attributes, to provide an objective method for choosing among the available options in Egypt.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>We conducted a systematic review and expert interviews, to identify the relevant criteria for inclusion in the tool. Subsequently, a workshop was conducted, that involved experts in procuring and tendering medical devices. Experts chose the criteria, ranked them, assigned weights and scoring functions for each criterion, and then created the draft tool. A pilot phase followed; then, another workshop was conducted to fine-tune the tool. We readjusted the tool based on experts\u2019 experience with the draft tool.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The final tool included eight criteria, arranged according to their weightage: technical characteristics (29.4%), country of origin (19.5%), use in reference countries (14.9%), supply reliability (11.7%), previous use in tenders (9.0%), instant replacement within product variety (6.9%), pharmacovigilance (4.6%), and refund or replacement (4.0%). Each medical device was assessed on these eight criteria to achieve a final score, that was compared to the alternative devices\u2019 scores. Price is not included in the MCDA tool, but it will be added in the financial evaluation phase.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Decisionmakers could use the MCDA tool, to make evidence-based and objective decisions for purchasing implantable devices, in the Egyptian public sector. Post price evaluation, the product with the best value will be chosen for reimbursement.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Highlights<\/jats:title>\n                <jats:p><jats:list list-type=\"bullet\">\n                  <jats:list-item>\n                    <jats:p>We created an MCDA tool to help decision makers choose between alternative implantable medical devices in Egypt.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>The MCDA tool includes eight criteria, where price is evaluated as a separate step.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>\u201cTechnical characteristics\u201d and \u201ccountry of origin\u201d criteria carried the highest weights, thus representing approximately 50% of the decision.<\/jats:p>\n                  <\/jats:list-item>\n                <\/jats:list><\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12911-022-02025-y","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T09:05:57Z","timestamp":1667984757000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A multicriteria decision analysis (MCDA) tool to purchase implantable medical devices in Egypt"],"prefix":"10.1186","volume":"22","author":[{"given":"Baher","family":"Elezbawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Nader","family":"Fasseeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertalan","family":"N\u00e9meth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Gamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Eldebeiky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remonda","family":"Refaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimaa","family":"Rabiea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soha","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasnaa","family":"Noaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany Bahaa","family":"Eldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossam","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Nouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif","family":"Abaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e0n","family":"Kal\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,9]]},"reference":[{"key":"2025_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1001\/jama.2013.286274","volume":"311","author":"JFDA Jin","year":"2014","unstructured":"Jin JFDA. FDA authorization of medical devices. JAMA. 2014;311:435. https:\/\/doi.org\/10.1001\/jama.2013.286274.","journal-title":"JAMA"},{"key":"2025_CR2","unstructured":"World Health Organization. Medical devices. 2022. https:\/\/www.who.int\/health-topics\/medical-devices#tab=tab_1. Accessed 19\/4\/2022."},{"key":"2025_CR3","unstructured":"Health Products Regulatory Authority. Implantable medical devices. 2022. http:\/\/www.hpra.ie\/homepage\/medical-devices\/safety-information\/consumer-advice\/implantable-medical-devices. Accessed 13\/4\/2022."},{"key":"2025_CR4","unstructured":"ECRI. Device evaluations. 2022. https:\/\/www.ecri.org\/solutions\/device-evaluations. Accessed 19\/4\/2022."},{"key":"2025_CR5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/mcda.1764","volume":"29","author":"S Tallarico","year":"2022","unstructured":"Tallarico S, Aloini D, Dulmin R, Lazzini S, Mininno V, Pellegrini L. Health technology assessment of medical devices. Overcoming the critical issues of current assessment. J Multi Criteria Decis Anal. 2022;29:150\u201372. https:\/\/doi.org\/10.1002\/mcda.1764.","journal-title":"J Multi Criteria Decis Anal."},{"key":"2025_CR6","doi-asserted-by":"publisher","first-page":"1968741","DOI":"10.1080\/23311916.2021.1968741","volume":"8","author":"MA Shbool","year":"2021","unstructured":"Shbool MA, Arabeyyat OS, Al-Bazi A, AlAlaween WH. An integrated multi-criteria decision-making framework for a medical device selection in the healthcare industry. Cogent Eng. 2021;8:1968741. https:\/\/doi.org\/10.1080\/23311916.2021.1968741.","journal-title":"Cogent Eng"},{"key":"2025_CR7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12911-018-0663-1","volume":"18","author":"TDC Fraz\u00e3o","year":"2018","unstructured":"Fraz\u00e3o TDC, Camilo DGG, Cabral ELS, Souza RP. Multicriteria decision analysis (MCDA) in health care: a systematic review of the main characteristics and methodological steps. BMC Med Inform Decis Mak. 2018;18:90. https:\/\/doi.org\/10.1186\/s12911-018-0663-1.","journal-title":"BMC Med Inform Decis Mak"},{"key":"2025_CR8","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1186\/s12913-018-3805-3","volume":"18","author":"A Inotai","year":"2018","unstructured":"Inotai A, Brixner D, Maniadakis N, Dwiprahasto I, Kristin E, Prabowo A, et al. Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals\u2014an application on improving tender decision making in Indonesia. BMC Health Serv Res. 2018;18:1003. https:\/\/doi.org\/10.1186\/s12913-018-3805-3.","journal-title":"BMC Health Serv Res"},{"key":"2025_CR9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3389\/fpubh.2018.00287","volume":"6","author":"A Baran-Kooiker","year":"2018","unstructured":"Baran-Kooiker A, Czech M, Kooiker C. Multi-Criteria Decision Analysis (MCDA) models in health technology assessment of orphan drugs\u2014a systematic literature review. Next steps in methodology development\u202f? Front Public Health. 2018;6:287. https:\/\/doi.org\/10.3389\/fpubh.2018.00287.","journal-title":"Front Public Health"},{"key":"2025_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/ACREFORE\/9780190625979.013.98","volume-title":"Multi-Criteria Decision Analysis (MCDA) in Healthcare Decision-Making","author":"P Hansen","year":"2019","unstructured":"Hansen P, Devlin N. Multi-Criteria Decision Analysis (MCDA) in Healthcare Decision-Making. Oxford: Oxford University Press; 2019. https:\/\/doi.org\/10.1093\/ACREFORE\/9780190625979.013.98."},{"key":"2025_CR11","unstructured":"Colliers. Egypt healthcare sector overview. 2021. https:\/\/www.colliers.com\/en-eg\/research\/cairo\/egypt-healthcare-overview. Accessed 19\/4\/2022."},{"key":"2025_CR12","unstructured":"Law No. 151 of 2019 Establishing the Egyptian Authority for Unified Procurement, Medical Supply and Supply, Medical Technology Management and the Egyptian Medicines Authority. 2019. https:\/\/manshurat.org\/node\/61255. Accessed 10\/4\/2022."},{"key":"2025_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40545-022-00414-2","volume":"15","author":"B Elezbawy","year":"2022","unstructured":"Elezbawy B, Fasseeh AN, Sedrak A, Eldessouki R, Gamal M, Eldebeiky M, et al. A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt. J Pharm Policy Pract. 2022;15:10. https:\/\/doi.org\/10.1186\/s40545-022-00414-2.","journal-title":"J Pharm Policy Pract"},{"key":"2025_CR14","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1097\/JCE.0000000000000104","volume":"40","author":"N Saleh","year":"2015","unstructured":"Saleh N, Sharawi AA, Wahed MA, Balestra G. A conceptual priority index for purchasing medical equipment in hospitals. J Clin Eng. 2015;40:E1-6. https:\/\/doi.org\/10.1097\/JCE.0000000000000104.","journal-title":"J Clin Eng"},{"key":"2025_CR15","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3846\/20294913.2014.943333","volume":"20","author":"I Ivlev","year":"2014","unstructured":"Ivlev I, Kneppo P, Bartak M. Multicriteria decision analysis: a multifaceted approach to medical equipment management. Technol Econ Dev Econ. 2014;20:576\u201389. https:\/\/doi.org\/10.3846\/20294913.2014.943333.","journal-title":"Technol Econ Dev Econ"},{"key":"2025_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jbi.2004.11.008","volume":"38","author":"G Ginsburg","year":"2005","unstructured":"Ginsburg G. Human factors engineering: A tool for medical device evaluation in hospital procurement decision-making. J Biomed Inform. 2005;38:213\u20139. https:\/\/doi.org\/10.1016\/j.jbi.2004.11.008.","journal-title":"J Biomed Inform"},{"key":"2025_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.11647\/OBP.0195.06","volume-title":"Non-communicable Disease Prevention: Best Buys, Wasted Buys and Contestable Buys","author":"DD Kim","year":"2019","unstructured":"Kim DD, Bacon RL, Neumann PJ, Culyer A. Assessing the transferability of economic evaluations: a decision framework. In: Non-communicable Disease Prevention: Best Buys, Wasted Buys and Contestable Buys. Open Book Publishers; 2019. p. 91\u2013117. https:\/\/doi.org\/10.11647\/OBP.0195.06."},{"key":"2025_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2217\/cer-2018-0102","volume":"8","author":"B N\u00e9meth","year":"2019","unstructured":"N\u00e9meth B, Moln\u00e1r A, Boz\u00f3ki S, Wijaya K, Inotai A, Campbell JD, et al. Comparison of weighting methods used in multicriteria decision analysis frameworks in healthcare with focus on low- and middle-income countries. J Comp Eff Res. 2019;8:195\u2013204. https:\/\/doi.org\/10.2217\/cer-2018-0102.","journal-title":"J Comp Eff Res"},{"key":"2025_CR19","first-page":"247","volume-title":"Conflicting objectives in decisions","author":"W Edwards","year":"1977","unstructured":"Edwards W. How to use multiattribute utility measurement for social decision making. In: De Bell KR, Raiffa H, editors. Conflicting objectives in decisions. Chichester: John Wiley & Sons; 1977. p. 247\u201376."},{"key":"2025_CR20","unstructured":"Von Winterfeldt D, Edwards W. Decision analysis and behavioral research. 1993."},{"key":"2025_CR21","unstructured":"MoHP. List of reference countries\u2014General Technical Regulatory Rules. 2021. https:\/\/www.edaegypt.gov.eg\/media\/dl5fxuzw\/general_tech_regulatory_rules_biologicals-and-inno.pdf. Accessed 1\/2\/2022."}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-022-02025-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-022-02025-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-022-02025-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T21:23:33Z","timestamp":1668029013000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-022-02025-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2025"],"URL":"https:\/\/doi.org\/10.1186\/s12911-022-02025-y","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,9]]},"assertion":[{"value":"26 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Syreon Middle East was a contractual partner of Edwards Lifesciences. ANF, SA and ZK are shareholders in Syreon Middle East. BE is an employee at Syreon Middle East. All other authors declare no conflict of interest. The authors declare that their affiliations did not influence their roles in the research and that all research steps were conducted independent from any potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"289"}}